Kamal M. El‐Gamal

Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers

Hazem A. Mahdy, M.K. Ibrahim, Ahmed M. Metwaly et al. · Bioorganic Chemistry · 2019 · 163 citations

Medicinal Chemistry, Novel Therapy, Medicine +9

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects

Mohamed Alswah, Ashraf H. Bayoumi, Kamal M. El‐Gamal et al. · Molecules · 2017 · 108 citations · Full text

Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors

Kamal M. El‐Gamal, Ahmed El-morsy, Ahmad M. Saad et al. · Journal of Molecular Structure · 2018 · 83 citations

Medicinal Chemistry, New Quinoline-3-carbonitrile Derivatives, Biochemistry +12

Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors

Ibrahim H. Eissa, Ahmed M. Metwaly, Amany Belal et al. · Archiv der Pharmazie · 2019 · 72 citations

Pharmacophore‐linked pyrazolo[3,4‐<i>d</i>]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies

Ahmed A. Abdel Gaber, Ahmed El-morsy, Farag F. Sherbiny et al. · Archiv der Pharmazie · 2021 · 71 citations